Home  >  News
you can get e-magazine links on WhatsApp. Click here
Research + Font Resize -

DKMS John Hansen Grant endowed with €240,000 for blood cancer research calls for applications

Our Bureau, Bengaluru
Friday, August 12, 2022, 16:40 Hrs  [IST]

DKMS John Hansen Research Grant is endowed with €240,000 each for blood cancer research which will be paid out over a period of three years. Scientists with a research focus on stem cell transplantation and cell therapy are invited to apply for the 2023 grant started from August 10, 2022.
John A. Hansen, after whom the grant is named, was an outstanding oncologist and distinguished immunogeneticist at the renowned Fred Hutchinson Cancer Research Center in Seattle.
With this grant, the DKMS Stiftung Leben Spenden (Foundation for Giving Life) supports up to four outstanding research projects each year that aim to advance the medical progress and improve the chances of recovery for blood cancer patients. The requirements include a doctoral degree (PhD, MD or equivalent) that was obtained no longer than 10 years ago. The application deadline is December 2, 2022.
In India, DKMS operates as DKMS BMST Foundation India, which is a joint venture with BMST (Bangalore Medical Services Trust). DKMS-BMST was officially launched on May 28, 2019 to give every blood cancer and blood disorder patient in need with a second chance at life.
Since its launch, DKMS-BMST has organized over 1300 donor registration events across various organisations such as corporates, educational institutes, hospitals and defence forces to raise awareness about blood stem cell donation and enrol more potential donors. So far, DKMS-BMST has successfully registered over 70,000 potential blood stem cell donors from India and provided 64 patients with a second chance at life.
Every year, more than 1.3 million people worldwide are diagnosed with blood cancer. A blood stem cell transplantation saves the lives of many of them. However, by far not all patients are permanently cured afterwards. Relapses and severe complications, especially graft-versus-host disease, still pose a great challenge for medicine and science.
Therefore, DKMS is committed to medical progress beyond its original tasks as a stem cell donor centre. An important pillar of this commitment is the promotion of young scientists.
"Our goal is to help as many patients as possible, across the globe. To achieve this goal, we must continue to develop and improve stem cell transplantation and other cellular therapies. It is therefore vital that the best research in this field is secured for the future. We are very pleased to be able to contribute towards this with the DKMS John Hansen Research Grant, which supports research by talented early career physicians and scientists," said Professor Dr. Marcel van den Brink, Chairman, DKMS Medical Council.


* Name :     
* Email :    
  Website :  
Copyright © 2016 Saffron Media Pvt. Ltd |